Live Markets »News & Advice»Latest Stories»Latest Stories Details
Latest Stories Details

Dishman Pharma Q1 net up over two fold at Rs 38.70 cr

Press Trust of India/New Delhi 31 Jul 12 | 06:53 PM
 Dishman Pharmaceuticals and Chemicals Ltd

BSE   24 May 16 | 12:00 AM

154.75  2.4 (1.58%)

NSE   24 May 16 | 12:00 AM

155.10  2.45 (1.61%)

Dishman Pharmaceuticals and Chemicals today reported an over two fold increase in its consolidated net profit to Rs 38.70 crore for the quarter ended June 30, 2012 mainly on account of robust performance in its  contract research and manufacturing services segment.

The company had posted a net profit of Rs 15.12 crore for the corresponding period previous fiscal.

Related Stories

    No Related Stories Found

Consolidated net sales of the company also rose to Rs 315.27 crore for the quarter under consideration from Rs 237.20 crore for the same period year ago, Dishman Pharmaceuticals and Chemicals said in a BSE filing.

In another filing to the BSE, the company said its Board of Directors has recommended payment of dividend at the rate of 60% on the paid up equity share capital of Rs 16,13,94,272  (Rs 1.20 per equity share of Rs 2 each) for the financial year 2011-12.

Shares of Dishman Pharmaceuticals and Chemicals today closed at Rs 69.70 on the BSE, up 6.74% from the previous close.


Company Price Gain (%)
Tata Motors389.251.70
ICICI Bank224.401.56
Tata Steel317.601.28
H D F C1,173.301.09


Will the Nifty top 8,000 if the BJP manages to win Assam assembly elections?

Online Portfolio

You can create Online Portfolio here using the below button.